Medications

More biosimilars marketed in Germany, Switzerland than U.S.

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

Medications

High R&D isn't necessarily why drugs are so expensive

In the first known study of its type, an international team of researchers evaluated whether high research and development (R&D) costs explain high drug prices in the United States.

page 8 from 40